| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5543150 | ALLERGAN | Method of progesterone delivery and affect thereof |
Sep, 2013
(10 years ago) | |
Crinone is owned by Allergan.
Crinone contains Progesterone.
Crinone has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Crinone are:
- US5543150
Crinone was authorised for market use on 31 July, 1997.
Crinone is available in gel;vaginal dosage forms.
Crinone can be used as vaginal administration of progesterone using specified formulation.
The generics of Crinone are possible to be released after 15 September, 2013.
Drugs and Companies using PROGESTERONE ingredient
Market Authorisation Date: 31 July, 1997
Treatment: Vaginal administration of progesterone using specified formulation
Dosage: GEL;VAGINAL
More Information on Dosage
CRINONE family patents
